S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
NASDAQ:TRHC

Tabula Rasa HealthCare Stock Forecast, Price & News

$10.35
-0.71 (-6.42%)
(As of 12/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$10.22
$11.72
50-Day Range
$10.35
$31.18
52-Week Range
$10.22
$69.31
Volume
391,058 shs
Average Volume
352,307 shs
Market Capitalization
$266.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.9
30 days | 90 days | 365 days | Advanced Chart
Receive TRHC News and Ratings via Email

Sign-up to receive the latest news and ratings for Tabula Rasa HealthCare and its competitors with MarketBeat's FREE daily newsletter.


Tabula Rasa HealthCare logo

About Tabula Rasa HealthCare

Tabula Rasa Healthcare, Inc. is a healthcare technology company, which engages in the development of solutions designed for pharmacists, providers, and patients to optimize medication regimens. It operates through the following segments: CareVention HealthCare and MedWise HealthCare. The CareVention HealthCare segment provides services, PACE, which is a center for Medicare & Medicaid services, or CMS, sponsored program providing medical and social services. Its brands include CareKinesis, Capstone Risk Adjustment Services, PACElogic, TruChart, PeakTPA, PersonifilRx, and Pharmastar. The MedWise HealthCare segment provides Medication Therapy Management, or MTM, software and services for Medicare, Medicaid, and commercial health plans, and also provides a cloud-based patient engagement software and services. It offers cloud-based software and clinical pharmacist services through its brands, including MedWise, SinfoníaRx, RxCompanion, PrescribeWellness, and DoseMeRx. The company was founded by Calvin H. Knowlton, Orsula V. Knowlton, and Michael Greenhalgh in April 2009 and is headquartered in Moorestown, NJ.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:TRHC
Fax
N/A
Employees
1,614
Year Founded
N/A

Sales & Book Value

Annual Sales
$297.22 million
Cash Flow
$1.21 per share
Book Value
$2.61 per share

Profitability

Net Income
$-80.97 million
Pretax Margin
-27.06%

Debt

Price-To-Earnings

Miscellaneous

Free Float
23,096,000
Market Cap
$266.19 million
Optionable
Optionable

Company Calendar

Last Earnings
11/04/2021
Today
12/04/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
2/22/2022

MarketRank

Overall MarketRank

2.67 out of 5 stars

Medical Sector

61st out of 1,390 stocks

Business Services, Not Elsewhere Classified Industry

17th out of 137 stocks

Analyst Opinion: 4.2Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 4.2Valuation: 0.6 5 -4 -3 -2 -1 -












Tabula Rasa HealthCare (NASDAQ:TRHC) Frequently Asked Questions

Is Tabula Rasa HealthCare a buy right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Tabula Rasa HealthCare in the last twelve months. There are currently 6 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Tabula Rasa HealthCare stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TRHC, but not buy additional shares or sell existing shares.
View analyst ratings for Tabula Rasa HealthCare
or view top-rated stocks.

How has Tabula Rasa HealthCare's stock been impacted by Coronavirus?

Tabula Rasa HealthCare's stock was trading at $45.88 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, TRHC shares have decreased by 77.4% and is now trading at $10.35.
View which stocks have been most impacted by COVID-19
.

When is Tabula Rasa HealthCare's next earnings date?

Tabula Rasa HealthCare is scheduled to release its next quarterly earnings announcement on Tuesday, February 22nd 2022.
View our earnings forecast for Tabula Rasa HealthCare
.

How were Tabula Rasa HealthCare's earnings last quarter?

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) posted its earnings results on Thursday, November, 4th. The company reported ($0.04) earnings per share for the quarter, topping analysts' consensus estimates of ($0.19) by $0.15. The firm earned $86.60 million during the quarter, compared to analysts' expectations of $88.54 million. Tabula Rasa HealthCare had a negative net margin of 27.37% and a negative trailing twelve-month return on equity of 44.56%. The company's revenue was up 22.8% on a year-over-year basis. During the same period in the previous year, the company posted ($0.35) earnings per share.
View Tabula Rasa HealthCare's earnings history
.

What guidance has Tabula Rasa HealthCare issued on next quarter's earnings?

Tabula Rasa HealthCare issued an update on its FY 2021 earnings guidance on Thursday, November, 25th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $329.60 million-$331.60 million, compared to the consensus revenue estimate of $342.36 million.

What price target have analysts set for TRHC?

9 Wall Street analysts have issued 12-month price targets for Tabula Rasa HealthCare's shares. Their forecasts range from $13.00 to $53.00. On average, they expect Tabula Rasa HealthCare's stock price to reach $29.00 in the next twelve months. This suggests a possible upside of 180.2% from the stock's current price.
View analysts' price targets for Tabula Rasa HealthCare
or view top-rated stocks among Wall Street analysts.

Who are Tabula Rasa HealthCare's key executives?

Tabula Rasa HealthCare's management team includes the following people:

What is Calvin H. Knowlton, BScPharm, MDiv, PhD's approval rating as Tabula Rasa HealthCare's CEO?

24 employees have rated Tabula Rasa HealthCare CEO Calvin H. Knowlton, BScPharm, MDiv, PhD on Glassdoor.com. Calvin H. Knowlton, BScPharm, MDiv, PhD has an approval rating of 91% among Tabula Rasa HealthCare's employees. This puts Calvin H. Knowlton, BScPharm, MDiv, PhD in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Tabula Rasa HealthCare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tabula Rasa HealthCare investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), QUALCOMM (QCOM), Adobe (ADBE), Micron Technology (MU), (CGC), Boeing (BA), salesforce.com (CRM), Intel (INTC) and Netflix (NFLX).

When did Tabula Rasa HealthCare IPO?

(TRHC) raised $60 million in an IPO on Thursday, September 29th 2016. The company issued 4,300,000 shares at a price of $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray served as the underwriters for the IPO and Baird and Stifel were co-managers.

What is Tabula Rasa HealthCare's stock symbol?

Tabula Rasa HealthCare trades on the NASDAQ under the ticker symbol "TRHC."

Who are Tabula Rasa HealthCare's major shareholders?

Tabula Rasa HealthCare's stock is owned by a variety of institutional and retail investors. Top institutional investors include Macquarie Group Ltd. (10.34%), Baillie Gifford & Co. (4.22%), Geneva Capital Management LLC (4.17%), Credit Suisse AG (2.01%), Bank of New York Mellon Corp (1.77%) and Geode Capital Management LLC (1.50%). Company insiders that own Tabula Rasa HealthCare stock include Andrea Carolan Speers, Brian W Adams, Calvin H Knowlton, Dennis Helling, Gordon Tunstall, Jan Berger, Michael Greenhalgh, Orsula V Knowlton, Orsula V Knowlton and Samira Beckwith.
View institutional ownership trends for Tabula Rasa HealthCare
.

Which major investors are selling Tabula Rasa HealthCare stock?

TRHC stock was sold by a variety of institutional investors in the last quarter, including New York State Common Retirement Fund, Citigroup Inc., Credit Suisse AG, Dimensional Fund Advisors LP, Millennium Management LLC, Jacob Asset Management of New York LLC, Lombard Odier Asset Management Switzerland SA, and Geneva Capital Management LLC. Company insiders that have sold Tabula Rasa HealthCare company stock in the last year include Andrea Carolan Speers, Brian W Adams, Calvin H Knowlton, Gordon Tunstall, Michael Greenhalgh, Orsula V Knowlton, and Samira Beckwith.
View insider buying and selling activity for Tabula Rasa HealthCare
or view top insider-selling stocks.

Which major investors are buying Tabula Rasa HealthCare stock?

TRHC stock was acquired by a variety of institutional investors in the last quarter, including Tudor Investment Corp Et Al, Squarepoint Ops LLC, Exchange Traded Concepts LLC, Duality Advisers LP, Marshall Wace LLP, Vontobel Holding Ltd., GSA Capital Partners LLP, and Jane Street Group LLC. Company insiders that have bought Tabula Rasa HealthCare stock in the last two years include Dennis Helling, and Jan Berger.
View insider buying and selling activity for Tabula Rasa HealthCare
or or view top insider-buying stocks.

How do I buy shares of Tabula Rasa HealthCare?

Shares of TRHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Tabula Rasa HealthCare's stock price today?

One share of TRHC stock can currently be purchased for approximately $10.35.

How much money does Tabula Rasa HealthCare make?

Tabula Rasa HealthCare has a market capitalization of $266.19 million and generates $297.22 million in revenue each year. The company earns $-80.97 million in net income (profit) each year or ($3.85) on an earnings per share basis.

How many employees does Tabula Rasa HealthCare have?

Tabula Rasa HealthCare employs 1,614 workers across the globe.

What is Tabula Rasa HealthCare's official website?

The official website for Tabula Rasa HealthCare is www.tabularasahealthcare.com.

Where are Tabula Rasa HealthCare's headquarters?

Tabula Rasa HealthCare is headquartered at 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057.

How can I contact Tabula Rasa HealthCare?

Tabula Rasa HealthCare's mailing address is 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057. The company can be reached via phone at (866) 648-2767 or via email at [email protected].


This page was last updated on 12/4/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.